Aug 12, 2020
New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients
Aug 05, 2020
AbbVie Announces Serena Williams as Spokesperson to Shed Light on UBRELVY® (ubrogepant) as an Effective Treatment Option for Migraine Attacks
Jun 18, 2020
RINVOQ(TM) (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 17, 2020
AbbVie Declares Quarterly Dividend
Jun 17, 2020
Halozyme To Participate In The BMO 2020 Prescriptions For Success Healthcare Conference
Jun 16, 2020
$274.6 Billion Worldwide Immunotherapy Drugs Industry to 2025 - Featuring Abbvie, Amgen & Boehringer Ingelheim Among Others
Jun 16, 2020
Fund+ Announces Investment in Ona Therapeutics EUR30 Million Series A Financing
Jun 15, 2020
FDA Approves JUVÉDERM® VOLUMA(TM) XC for Enhancement of the Chin Region
Jun 13, 2020
VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients
Jun 13, 2020
Halozyme Announces Findings From Janssen's Phase 3 Andromeda Study Evaluating Subcutaneous Daratumumab Utilizing ENHANZE® In Light-Chain Amyloidosis Presented At European Hematology Association 25th Annual Congress
Jun 12, 2020
AbbVie Recommends Shareholders Reject TRC Capital's "Mini-Tender" Offer
Jun 12, 2020
AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 Weeks
Jun 10, 2020
AbbVie and Genmab Announce Broad Oncology Collaboration
Jun 09, 2020
2020 CMO Scorecard: CMO Industry Performance and Relative Performance of Major CMOs
Jun 08, 2020
Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal
Jun 03, 2020
AbbVie to Present at the Virtual Goldman Sachs 41st Annual Global Healthcare Conference
Jun 01, 2020
Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients
Jun 01, 2020
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
May 29, 2020
FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women